Key Takeaways Ozempic/Wegovy can help people with fatty liver diseasePeople on the drug had less liver inflammation and ...

The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials ...

PYRUKYND Net Revenue of $8.7 Million in Q1; Cash, Cash Equivalents and Marketable Securities of $1.4 Billion as of March 31, 2025 - CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Agios ...

The Melbourne-based company says it has landed one of the biggest licensing deals in Australian biotech history.